Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
3M Signs Development Agreement; Updates Phosphagenics Collaboration
3M Drug Delivery Systems and Radius Health, Inc. recently announced an agreement to collaborate on the development of a transdermal...Critical Outcome Technologies Initiates Development of Optimal Oral Oncology Formulation
Critical Outcome Technologies Inc. recently announced it has initiated a project to develop an optimal oral formulation of COTI-2. This...Capsugel Acquires Novel FlexTab Delivery Technology
Capsugel, the world's leading hard capsule manufacturer and an innovator in drug delivery systems, recently announced its acquisition of the FlexTabTM...SPECIAL REPORT - Excited About Excipients?
Kurt R. Sedo and Cindy H. Dubin take a deep dive into the excipient market, highlighting how new excipients enable advanced drug products and how AI and computation tools are helping match excipients to APIs.
DRUG DELIVERY - Powder to Patient: Advancing Reconstitutable Injectables Through Integrated Aseptic Powder Filling & Next-Generation Dual Chamber Delivery
Laxman Halleppanavar and David Phasey offer a focused perspective on connecting formulation, particle engineering, aseptic manufacturing, device design, and patient use within one scalable development pathway.
SPECIAL FEATURE - Injection Devices: Advancements Converge to Expand Patient Possibilities
Cindy H. Dubin speaks with injection device developers about creating devices that are intelligent, intuitive, patient-centric systems that make advanced therapies easier, safer, and more accessible to use at home.
Why NAMs Took Decades to Arrive – and Why iPSCs are Making Them Possible
When US and European regulators acted in recent years to support the use of animal model alternatives for drug development, reactions were mixed. There is broad acknowledgement regarding the limitations of animal-based disease models and their inability to fully recapitulate human biological complexity, contributing to a high clinical failure rate, and so there was true excitement for the possibilities.
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals – Corporate HQ 7200 Industrial Row Drive Suite 200 Mason, OH 45040 (513) 984-5000 contact@aprecia.com LinkedIn | YouTube Aprecia...InnoGI Technologies Launches TIM Cell to Bridge the Gap Between Bioaccessibility and Absorption
Delft, The Netherlands, InnoGI Technologies announced the launch of TIM Cell, a novel apparent permeability service designed specifically to work...SPECIAL REPORT - Advancements in Respiratory Drug Delivery
Advances in inhaled drug delivery are improving how therapies reach the lungs, with innovations in formulations, devices, biologics, and digital tools helping expand treatment options for respiratory diseases.
